Alison Skrinar

Alison Skrinar has a diverse work experience in the pharmaceutical industry. Alison started their career in 2001 at Genzyme as a Director of Clinical Outcomes, where they worked until 2009. Skrinar then joined Enobia Pharma as a Senior Director of Clinical Research and Regulatory Affairs, holding that role until 2012. In 2012, they moved to Ultragenyx Pharmaceutical Inc. and currently serves as the Vice President of Clinical Outcomes Research and Evaluation.

Alison Skrinar received their Bachelor of Business Administration (BBA) degree in Finance from Emory University in 1992. Alison then pursued further education at the University of Alabama at Birmingham, where they completed their MA, MPH, and PhD degrees in Medical Psychology and Outcomes Research from 1996 to 2000.